Va
Valo Health
Boston MAFounded 2019200 employees
Private CapbiotechPrivateOncology
Platform: AI Computation
Market Cap
N/A
All Drugs
3
Clinical Trials
4
Failed / Terminated
0
FDA Approved
0
Drug Pipeline (3 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| VAL-3792 | VAL-3792 | Phase 1/2 | 1 | PD-1 | Crohn'sCF | ||
| VAL-6020 | VAL-6020 | Phase 2/3 | 1 | JAK2 | Urothelial CaAS | ||
| Pemitenlimab | VAL-6747 | Phase 3 | 2 | Tau | NSCLCUrothelial Ca |
Financial Documents
This is a private company — SEC filings are not available.
Catalyst Events (4)